News
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.
Everyone says they’re using AI in 2025, but how does the FDA actually plan to take advantage of the technology to improve efficiency at the agency? Well, just last week, the FDA launched Elsa ...
The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results